One of Novo Nordisk's next-generation obesity shots to follow up on its success with Wegovy helped patients lose 22% of their ...

One of Novo Nordisk's next-generation obesity shots to follow up on the success of Wegovy helped patients lose 22% of their ...

Novo Nordisk today announced topline results from a phase 1b/2a clinical trial with amycretin, a unimolecular GLP-1 and amylin receptor agonist intended for once weekly ...

The company has so far only launched Wegovy in the U.S., Britain, Germany, Norway, and its home market Denmark. Wegovy is the first-to-market in a new class of highly effective weight-loss drugs.

This issue is preventing our website from loading properly. Please review the following troubleshooting tips or contact us at [email protected]. By submitting your ...

President Trump told Denmark’s leader he wanted to take over ... capitols and local government offices, leaving them at a loss on how to calculate its impact. Federal Work Force: The Trump ...

Denmark said on Monday it would spend 14.6 billion Danish kroner ($2.05 billion) boosting its military capabilities in the Arctic – a decision that comes amid continuing furor following US Presi ...

It came after Denmark said on Monday it plans to spend $2.05 billion to boost its military presence in the Arctic. While the Scandinavian country is responsible for Greenland's security and ...

By Kenneth P. Vogel Reporting from Washington The government of Denmark has not historically been a big spender on Washington lobbying. But days before President Trump took office for a second ...

Novo Nordisk's U.S.-listed shares are surging 9% Friday morning after the Danish drugmaker reported early stage results for ...

US president spoke to Danish premier for 45 minutes last week and made clear he wanted to place Greenland under American control Denmark is in “crisis mode” after Donald Trump made a direct ...